Revenue growth, expansion, awards: TRACOE medical records positive results for the 2016 financial year

»» Total revenues for the group increased to EUR 26.8 million.

»» Expansion into the United Kingdom is now complete

»» Important steps setting the course for the future

With the acquisition of the British company KAPITEX Healthcare Ltd. by TRACOE medical‘s parent company XTR Group GmbH, the company was able to once more significantly increase its access to the important laryngectomy market and further accelerate its growth. The turnover of the XTR Group, to which, besides TRACOE medical and KAPITEX, the further subsidiary MC Europe B.V. also belongs, totalled around EUR 26.8 million in 2016, of which TRACOE medical alone generated EUR 20.5 million. Receiving the seal of approval as a winner of the ‚TOP 100‘ award, which honours the top 100 innovative businesses in Germany, and our operational measures in the areas development, production and distribution, rounded off the successful financial year. 

Stephan Köhler, managing director of TRACOE medical GmbH, which currently has a workforce of around 200 employees: „2016 was an extremely challenging, but also a very successful year, during which we took some important strategic steps for the further development of the company. Especially the takeover of KAPITEX and its integration into the holding company was a milestone and will significantly further strengthen our market position as a premium supplier”.

Find more information here.